Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma
Anne Pham‐Ledard, Martina Prochazkova‐Carlotti, Lætitia Andrique et al. · Modern Pathology · 2013
Cited by 90 works. doi:10.1038/modpathol.2013.156 Open-access PDF
Authors
- Anne Pham‐Ledard
- Martina Prochazkova‐Carlotti
- Lætitia Andrique
- David Cappellen
- Béatrice Vergier
- Fabián Martínez
- Florent Grange
- Tony Petrella
- Marie Beylot-Barry
- Jean‐Philippe Merlio
References
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
- WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
- WHO-EORTC classification for cutaneous lymphomas
- WHO classification of haematolymphoid tumours
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
- Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- Oncogenically active MYD88 mutations in human lymphoma